1- Beedy P,
Moyle P,
Kataoka M,
et al.
Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging.
Radiology 2011;262(2):530-537.
2- Sala E,
Bockall A,
Kubik Buch RA,.
Advances in magnetic resonance imaging of endometrial cancer.
Eur Radiol 2011;21(3):408-473.
3- Rechichi G,
Galimberti S,
Signorelli M,
et al.
Myometrial invasion in endometrial cancer: diagnostic performance of diffusion weighted MR imaging at 1.5T.
Eur Radiol 2010;20(3):754-762.
4- Sala E,
Crawford R,
Senior E,
et al.
Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma.
Int J Gynecol Cancer 2009;19(1):141-146.
5- Sala E,
Rockall A,
Rangarajan D,
et al.
The role of dynamic contrast enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
Eur Radiol 2010;76(3):367-385.
6- Yamashita Y,
Harada M,
Sawada T,
et al.
Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging.
Radilogy 1993; 186(2):495-501.
7- Sironi S,
Colombo E,
Villa G,
et al.
Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging.
Radiology 1992; 185 (1):207-212.
8- Frey KA,
Kinkel K,
Bonel HM,
et al.
Prediction of deep myometrial invasion in patients with endometrial cancer,
clinical utility of contrast-enhanced MR imaging- a metanalysis and Bayesin analysis.
Radiology 2000; 216(2):444-449.